210 related articles for article (PubMed ID: 36003298)
1. Motor, epileptic, and developmental phenotypes in genetic disorders affecting G protein coupled receptors-cAMP signaling.
Galosi S; Pollini L; Novelli M; Bernardi K; Di Rocco M; Martinelli S; Leuzzi V
Front Neurol; 2022; 13():886751. PubMed ID: 36003298
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation.
Lasa-Aranzasti A; Larasati YA; da Silva Cardoso J; Solis GP; Koval A; Cazurro-Gutiérrez A; Ortigoza-Escobar JD; Miranda MC; De la Casa-Fages B; Moreno-Galdó A; Tizzano EF; Gómez-Andrés D; Verdura E; Katanaev VL; Pérez-Dueñas B;
Mov Disord; 2024 Jun; ():. PubMed ID: 38881224
[TBL] [Abstract][Full Text] [Related]
3. GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey.
JoJo Yang QZ; Porter BE; Axeen ET
Epilepsy Behav Rep; 2023; 21():100582. PubMed ID: 36654732
[TBL] [Abstract][Full Text] [Related]
4. Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.
Silachev D; Koval A; Savitsky M; Padmasola G; Quairiaux C; Thorel F; Katanaev VL
Acta Neuropathol Commun; 2022 Jan; 10(1):9. PubMed ID: 35090564
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlation and treatment effects in young patients with
Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A
J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region.
Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A
Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224
[TBL] [Abstract][Full Text] [Related]
7. A mechanistic review on GNAO1-associated movement disorder.
Feng H; Khalil S; Neubig RR; Sidiropoulos C
Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257
[TBL] [Abstract][Full Text] [Related]
8. Phenomenology and clinical course of movement disorder in GNAO1 variants: Results from an analytical review.
Schirinzi T; Garone G; Travaglini L; Vasco G; Galosi S; Rios L; Castiglioni C; Barassi C; Battaglia D; Gambardella ML; Cantonetti L; Graziola F; Marras CE; Castelli E; Bertini E; Capuano A; Leuzzi V
Parkinsonism Relat Disord; 2019 Apr; 61():19-25. PubMed ID: 30642806
[TBL] [Abstract][Full Text] [Related]
9. Fever-Induced and Early Morning Paroxysmal Dyskinesia in a Man With
Galosi S; Pollini L; Nardecchia F; Cellini E; Guerrini R; Leuzzi V
Mov Disord Clin Pract; 2022 Sep; 9(Suppl 2):S41-S43. PubMed ID: 36118517
[No Abstract] [Full Text] [Related]
10. GNAO1 Mutations Affecting the N-Terminal α-Helix of Gαo Lead to Parkinsonism.
Solis GP; Larasati YA; Thiel M; Koval A; Koy A; Katanaev VL
Mov Disord; 2024 Mar; 39(3):601-606. PubMed ID: 38358016
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis.
Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH
Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085
[TBL] [Abstract][Full Text] [Related]
12. Movement disorder in
Feng H; Sjögren B; Karaj B; Shaw V; Gezer A; Neubig RR
Neurology; 2017 Aug; 89(8):762-770. PubMed ID: 28747448
[TBL] [Abstract][Full Text] [Related]
13. Both subthalamic and pallidal deep brain stimulation are effective for
Liu Y; Zhang Q; Wang J; Liu J; Yang W; Yan X; Ouyang Y; Yang H
Ther Adv Neurol Disord; 2022; 15():17562864221093507. PubMed ID: 35509770
[TBL] [Abstract][Full Text] [Related]
14. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease.
Ferrini A; Steel D; Barwick K; Kurian MA
Mov Disord; 2021 May; 36(5):1104-1114. PubMed ID: 33934385
[TBL] [Abstract][Full Text] [Related]
15. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey.
Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP
Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551
[TBL] [Abstract][Full Text] [Related]
16. Genetic Dystonias: Update on Classification and New Genetic Discoveries.
Keller Sarmiento IJ; Mencacci NE
Curr Neurol Neurosci Rep; 2021 Feb; 21(3):8. PubMed ID: 33564903
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia.
Koy A; Cirak S; Gonzalez V; Becker K; Roujeau T; Milesi C; Baleine J; Cambonie G; Boularan A; Greco F; Perrigault PF; Cances C; Dorison N; Doummar D; Roubertie A; Beroud C; Körber F; Stüve B; Waltz S; Mignot C; Nava C; Maarouf M; Coubes P; Cif L
J Neurol Sci; 2018 Aug; 391():31-39. PubMed ID: 30103967
[TBL] [Abstract][Full Text] [Related]
18. Severity of GNAO1-Related Disorder Correlates with Changes in G-Protein Function.
Domínguez-Carral J; Ludlam WG; Junyent Segarra M; Fornaguera Marti M; Balsells S; Muchart J; Čokolić Petrović D; Espinoza I; Ortigoza-Escobar JD; Martemyanov KA;
Ann Neurol; 2023 Nov; 94(5):987-1004. PubMed ID: 37548038
[TBL] [Abstract][Full Text] [Related]
19. Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement Disorder.
Menke LA; Engelen M; Alders M; Odekerken VJ; Baas F; Cobben JM
J Child Neurol; 2016 Dec; 31(14):1598-1601. PubMed ID: 27625011
[TBL] [Abstract][Full Text] [Related]
20. PDE10A Mutation as an Emerging Cause of Childhood-Onset Hyperkinetic Movement Disorders: A Review of All Published Cases.
Kalampokini S; Xiromerisiou G; Bargiotas P; Anastasiadou VC; Costeas P; Hadjigeorgiou GM
Neuropediatrics; 2024 Mar; ():. PubMed ID: 38442915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
